Senior > AMD
Enrollment complete in Graybug's phase 2b wet AMD treatment trial
14 days ago | Healio
The final patient has been enrolled in a phase 2b trial of Graybug Vision's wet age-related macular degeneration treatment candidate, according to a press release.
The...
Read more ...
Visual acuity, injection frequency decrease over time in real-world AMD study
15 days ago | Healio
In a retrospective study, patients with neovascular age-related macular degeneration treated with anti-VEGF injections experienced decreased visual acuity from baseline and...
Read more ...
Tooth-enamel protein discovered in the eyes of people with dry AMD
19 days ago | News Medical
A protein that normally deposits mineralized calcium in tooth enamel may also be responsible for calcium deposits in the back of the eye in people with dry age-related macular...
Read more ...
Final visual outcomes worse after anti-VEGF treatment lapse
23 days ago | Healio
PHILADELPHIA - Patients with neovascular age-related macular degeneration receiving intravitreal anti-VEGF injections should be encouraged to adhere to their treatment regimen...
Read more ...
Santen, Tracon discontinue development of wet AMD treatment
23 days ago | Healio
Santen and Tracon Pharmaceuticals have discontinued development of DE-122, their wet age-related macular degeneration treatment candidate, following data analysis of a phase 2a...
Read more ...
VIDEO: AI leads patients through head-mounted AMD test
28 days ago | Healio
ATLANTA - Maculogix has taken the 45-pound tabletop dark adaptation testing device, AdaptDx, and turned it into a head-mounted technology managed by an onboard artificial...
Read more ...
Scientists make important discovery with implications for people living with AMD
1 month ago | News Medical | 2 articles
Scientists from Trinity College Dublin have made an important discovery with implications for those living with a common, debilitating eye disease that can cause blindness.
Read more ...
Beovu approved for wet AMD in Europe
1 month ago | Healio
The European Commission has approved Beovu for the treatment of wet age-related macular degeneration, Novartis announced in a press release.
Beovu is the first anti-VEGF...
Read more ...
Repeated injections for AMD increase glaucoma risk
1 month ago | Healio
Researchers in Wheaton, Ill., reported that patients with age-related macular degeneration were more likely to develop glaucoma and its risk factor, ocular hypertension, when...
Read more ...
Periodontal disease may be risk factor for AMD
1 month ago | Healio
Periodontal diseases are a possible additional risk factor for age-related macular degeneration; however, the link between the two remains unclear, according to a literature...
Read more ...
Register you to post on Health Mag
Free Registration
New Biomarker in Blood Helps Detect Alzheimer's Early
Discovery of new biomarker- RNA produced by the PHGDH gene in blood could lead to early test for Alzheimer's disease. Read more ...